Stocks · Health care · Biological Products, (No Diagnostic Substances)

CG Oncology, Inc.

CGON Clue Score59
United States Fiscal year ends December CIK 0001991792 Results filed 6 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
100
$28.99
$2.90K
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
100
$28.96
$2.90K
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
30,105
$28.24
$850.17K
Hong Fang Song
3 Sep 2025
Director
Sold on a plan indirect
69,695
$27.60
$1.92M

What was left out

Form 4 filings counted 76
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 38
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 9,248,735
History held since 26 Jan 2024